Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension
Conditions
- Glaucoma
- Ocular Hypertension
Interventions
- DRUG: 0.2% brimonidine/0.5% timolol fixed combination ophthalmic solution
- DRUG: Concurrent brimonidine 0.2% and Timolol 0.5% ophthalmic solution
- DRUG: Brimonidine 0.2% ophthalmic solution
Sponsor
Allergan